505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA




Similar to 505(b)(2)

ACC - RCHSA Radiation Control for Health and Safety Act accession number ORA AofC code
ACCME - Accreditation Council for Continuing Medical Education
ACCP - American College of Clinical Pharmacology
ACE - Automated Commercial Environment
ACE - Adverse Clinical Event
ACEP - American College of Emergency Physicians
ACF - Administration for Children and Families

View all in FDA